𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Treatment for Localized Langerhans' Cell Histiocytosis of the Maxilla by Corticosteroid Injection

✍ Scribed by Nakagawa, Yoichi; Idesaki, Satoshi; Matsumoto, Kameji; Ishibashi, Katsunori

Book ID
123192843
Publisher
Wiley (John Wiley & Sons)
Year
2007
Tongue
English
Weight
292 KB
Volume
4
Category
Article
ISSN
1348-8643

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

β€œEtoposide in the treatment of six child
β€œEtoposide in the treatment of six children with langerhans cell histiocytosis (histiocytosis X)” by Viana et al.
✍ Whitlock, James A. πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 89 KB

Viana et al. [I] described their experience with etoposide (VP-16) as initial therapy in the management of patients with Langerhans cell histiocytosis (LCH). However, caution should be used in advocating the use of an epipodophyllotoxin as the "drug of choice" for the treatment of this disorder. Alt

2-chlorodeoxyadenosine (2-CDA) for the t
2-chlorodeoxyadenosine (2-CDA) for the treatment of refractory or recurrent Langerhans cell histiocytosis (LCH) in pediatric patients
✍ Stine, Kimo C.; Saylors, Robert L.; Williams, Laura L.; Becton, David L. πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 192 KB πŸ‘ 2 views

Background. Pediatric patients with Langerhans cell histiocytosis (LCH) may become refractory to conventional therapy or present with repeated recurrences over several years. Current therapeutic options such as prednisone, vinblastine, etoposide, and cyclosporine are associated with significant acut